🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Jefferies Group’s MRVI Holdings & Trades

First Buy
Q3 2023
Duration Held
10 Quarters
Largest Add
Q3 2024
+55,693 Shares
Current Position
17,000 Shares
$55,250 Value

Jefferies Group's MRVI Position Overview

Jefferies Group (via Jefferies Financial Group Inc.) currently holds 17,000 shares of Maravai LifeSciences Holdings, Inc. (MRVI) worth $55,250, representing 0.00% of the portfolio. First purchased in 2023-Q3, this medium-term investment has been held for 10 quarters.

Based on 13F filings, Jefferies Group has maintained a strategic position in MRVI, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 55,693 shares. Largest reduction occurred in Q4 2024, reducing 55,693 shares.

Analysis based on 13F filings available since 2013 Q2

Jefferies Group's Maravai LifeSciences Holdings (MRVI) Holding Value Over Time

Track share changes against reported price movement

Quarterly Maravai LifeSciences Holdings (MRVI) Trades by Jefferies Group

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2024 -55,693 Reduce 76.61% 17,000 $5.45
Q3 2024 +55,693 Add 327.61% 72,693 $8.31
Q2 2024 -27,500 Reduce 61.80% 17,000 $7.16
Q1 2024 +27,500 Add 161.76% 44,500 $8.67
Q4 2023 +1,753 Add 11.50% 17,000 $6.55
Q3 2023 +15,247 New Buy 15,247 $10.00

Jefferies Group's Maravai LifeSciences Holdings Investment FAQs

Jefferies Group first purchased Maravai LifeSciences Holdings, Inc. (MRVI) in Q3 2023, acquiring 15,247 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Jefferies Group has held Maravai LifeSciences Holdings, Inc. (MRVI) for 10 quarters since Q3 2023.

Jefferies Group's largest addition to Maravai LifeSciences Holdings, Inc. (MRVI) was in Q3 2024, adding 72,693 shares worth $604,079.

According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 17,000 shares of Maravai LifeSciences Holdings, Inc. (MRVI), valued at approximately $55,250.

As of the Q4 2025 filing, Maravai LifeSciences Holdings, Inc. (MRVI) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.

Jefferies Group's peak holding in Maravai LifeSciences Holdings, Inc. (MRVI) was 72,693 shares, as reported at the end of Q3 2024.